CClinicalTrials.gg
CompletedNCT06235658Updated Feb 27, 2026Results posted

Yoga in Older Cardiac Patients

An interventional study of Gentle Yoga in Cardiovascular Diseases in Old Age, sponsored by Geunyeong Cha. Completed at 1 site in United States. Open to participants aged 65 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by Geunyeong Cha · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
65 Years to 100 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare, at 3 months, the effects of a yoga intervention on physical health, including balance, muscle strength, physical activity levels, cardiac autonomic function, and physical vulnerability, as well as psychological health, including depressive symptoms and anxiety, in cardiac patients who are older than 65 years old and randomized to the intervention or control group. The main questions aim to 1) determine if yoga can improve physical health outcomes such as balance, muscle strength, cardiac function, and physical vulnerability in older adults with cardiovascular disease, and 2) determine if yoga can positively impact psychological health, including reducing depressive symptoms and anxiety in this population. Participants in the intervention group will attend yoga sessions twice a week for three months. The intervention group will be asked to complete surveys and physical function assessments at the beginning and three months later. Researchers will compare the intervention group and the control group to see if there is any difference and improvement in physical and psychological health between the two groups.

02

Conditions studied

  • Cardiovascular Diseases in Old Age

Browse trials for

Keywords

  • Physical Activity
  • Yoga
  • Mind-body therapies
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 36 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

This is the only study on the registry with Geunyeong Cha as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • have a history of an acute myocardial infarction within the preceding year, stable angina, cardiac surgery (including heart transplantation, valve surgery, or coronary artery bypass), coronary artery angioplasty or stents, or heart failure (ejection fraction \< 35%) diagnosed in the past year
  • have completed facility-based cardiac rehabilitation program (phase CR-II) within 12 months
  • can read and understand English
  • have no major comorbidities limiting their ability to participate in a yoga intervention
  • reside in Kentucky.

Exclusion criteria

Exclusion Criteria:

  • have incapacitating neurologic, orthopedic, or neoplastic conditions such as stroke paralysis, terminal cancer, or a cognitive disorder
  • currently practice yoga
  • have no home WIiFi access
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • No intervention
    Control

    Participants in the control group will not receive any intervention but will be provided with printed or electronic versions of the American Heart Association's 'Life's Essential 8' at baseline, which includes information on how to improve and maintain cardiovascular health.

  • Experimental
    Online Yoga Intervention

    Participants in the intervention group will attend two virtual 60-minute gentle yoga sessions per week for 12 weeks.

    Behavioral: Gentle Yoga

Interventions

  • BehavioralGentle Yoga

    Participants will attend two virtual 60-minute gentle yoga sessions per week for 12 weeks. Each session will be conducted via videoconference using the Zoom platform, with participants joining from their homes.

06

What researchers measure

Primary outcomes

  1. Recruitment Rate

    The recruitment rate (%) will be calculated by dividing the total number of patients enrolled by approached eligible patients and then multiplying it by 100.

    Time frame: Three months

  2. Number of Participants Who Completed the Study

    The completion rate of the study will be calculated by dividing the total number of patients by the number of patients who will complete the study and then multiplying it by 100.

    Time frame: Three months

  3. Intervention Adherence Rate

    The intervention adherence rate will be calculated by dividing the total number of sessions attended by the total number of intervention sessions (i.e., 24) and multiplying that number by 100.

    Time frame: Three months

  4. Intervention Acceptability

    The investigators will use modified versions of the Treatment Acceptability Adherence Scale (TAAS) to assess acceptability of the yoga intervention at 3-months follow-up. The TAAS is a 10-item self-report questionnaire designed to evaluate treatment acceptability and adherence. Items are rated on a 7-point Likert-type scale (1 = disagree strongly; 7 = agree strongly). The total score is a sum of ten items, ranging from 10 to 70 where a higher score means greater adherence.

    Time frame: Three months

  5. Intervention Satisfaction

    The investigators will use modified versions of the Client Satisfaction Questionnaire (CSQ) to assess the satisfaction of the yoga intervention at 3-month follow-up. The CSQ is an 8-item self-report questionnaire to evaluate participant satisfaction with a specific intervention. Items are rated on a 4-point Likert-type scale (1 = very satisfied; 4= quite dissatisfied). The total score is the sum of eight items, ranging from 8 to 32, where a higher score indicates greater satisfaction with the intervention. This instrument was validated for patients and has internal consistency reliability.

    Time frame: Three months

Secondary outcomes

  1. Change in Patient Health Questionnaire-9

    The Patient Health Questionnaire-9 (PHQ-9) was developed to correspond to symptoms used in the DSMV-IV to diagnose clinical depression. Nine symptoms are rated on a 4-point Likert scale (0 = 'Not at all; 3 = 'Nearly every day'), with possible total scores ranging from 0 to 27 and higher scores indicating higher levels of depressive symptoms.

    Time frame: Baseline and Three months

  2. Change in Brief Symptom Inventory

    The Brief Symptom Inventory (BSI), anxiety index, consists of 6 items rated on a 5-point Likert scale (0 = not at all; 4 = extremely). The total score ranges from 0 to 24, with a higher score reflecting greater anxiousness.

    Time frame: Baseline and Three months

  3. Change in Vulnerable Elders Survey 13

    The Vulnerable Elders Survey 13 (VES-13) includes four dimensions: age, self-assessment of health, physical function, and living function. Each domain is scored differently. Age is scored as follows: 75-84 years = 1 point, ≥ 85 years = 3 points. Self-rated health is categorized into "fair and poor" or "good", "very good", or "excellent", with only the "fair and poor" category scoring 1 point. The total score ranges from 0 to 15, with higher scores indicating greater vulnerability.

    Time frame: Baseline and Three months

  4. Change in Short-term Heart Rate Variability

    Short-term Heart Rate Variability (HRV) will be collected using the Polar H9 heart rate monitor (Polar Electro OY, Kempele, Finland). The investigator will send a reminder about the precautions to be taken (e.g., avoiding caffeine, alcohol, smoking, and intense physical activity, as these factors could affect the HRV measurement for successful HRV measurement the day before the scheduled test. The investigator will again ask if the instructions have been followed when they arrive for data collection. Study patients will be instructed to lay supine for 10 minutes without speaking and to remain as still as possible. The investigator will place the Polar H9 heart rate monitor on the center of the sternum to measure HRV. During HRV data collection, the study patients will also wear the ActiGraph on the waist because the Polar H9 communicates with the ActiGraph.

    Time frame: Baseline and Three months

  5. Muscle Strength at Baseline

    Muscle strengths will be measured using the handheld dynamometry (HHD, Lafayette dynamometer, model01165APP; Lafayette Instrument Company, Lafayette, Ind., USA). This device measures the peak force exerted in kilograms for five seconds during muscle contraction on hips and quadriceps.

    Time frame: Baseline

  6. Change in Balance

    Balance will be measured using an Inertial Measurement Unit device (DOTIMU; Xsens Technologies, Enschede., the Netherlands). The investigators attach the IMU sensor (a small device the size of a large watch face) to the participant's lower back at the level of L3 vertebra. Patients will be asked to take off their shoes and stand up on the mat with their hands on their hips for 30 seconds. The investigators will measure balance 3 times, with 30 seconds of rest between assessments. The total estimated time for the balance test is 3-5 minutes. All signal processing, subsequent feature extraction, and analysis will be performed using MATLAB version R2018B (The Mathworks Inc., Natick, MA, USA). The root-mean-square (RMS) value of the acceleration signal will be used to quantify the magnitude and trajectory of postural sway in each direction. The RMS of the magnitude vector of the 3-axis acceleration signal will be used as the summary score.

    Time frame: Baseline and Three months

  7. Change in Physical Activity

    Physical activity (PA) will be measured using actigraphy, the gold-standard for measuring physical activity. The investigator will use the ActiGraph (GT3X Link model), a triaxial instrument, which is the most widely used wearable accelerometer in clinical research. All patients will be instructed to wear the device for nine consecutive days, including at least one weekend day. Both baseline and 3-month values were calculated in a similar way.

    Time frame: Baseline and Three months

  8. Muscle Strength at 3 Months

    Muscle strengths will be measured using the handheld dynamometry (HHD, Lafayette dynamometer, model01165APP; Lafayette Instrument Company, Lafayette, Ind., USA). This device measures the peak force exerted in kilograms for five seconds during muscle contraction on hips and quadriceps.

    Time frame: Three months

07

Results

Posted Feb 27, 2026
Limitations and caveats
The measures of anxiety (Brief Symptom Index) and intervention acceptability although reported here have reliability issues.

Participant flow

Participant flow — Overall Study
MilestoneControlOnline Yoga Intervention
Started1719
Completed1516
Not completed23
Withdrew: Withdrawal by subject23

Outcome measures

PrimaryRecruitment Rate

The recruitment rate (%) will be calculated by dividing the total number of patients enrolled by approached eligible patients and then multiplying it by 100.

Time frame:
Three months
Reported as:
Count of participants · Participants
Recruitment Rate
ParticipantsOverall Study
Recruitment Rate36
PrimaryNumber of Participants Who Completed the Study

The completion rate of the study will be calculated by dividing the total number of patients by the number of patients who will complete the study and then multiplying it by 100.

Time frame:
Three months
Reported as:
Count of participants · Participants
Number of Participants Who Completed the Study
ParticipantsControlOnline Yoga Intervention
Number of Participants Who Completed the Study1516
PrimaryIntervention Adherence Rate

The intervention adherence rate will be calculated by dividing the total number of sessions attended by the total number of intervention sessions (i.e., 24) and multiplying that number by 100.

Time frame:
Three months
Reported as:
Number · percentage of sessions
Intervention Adherence Rate
percentage of sessionsOnline Yoga Intervention
Intervention Adherence Rate91.3
PrimaryIntervention Acceptability

The investigators will use modified versions of the Treatment Acceptability Adherence Scale (TAAS) to assess acceptability of the yoga intervention at 3-months follow-up. The TAAS is a 10-item self-report questionnaire designed to evaluate treatment acceptability and adherence. Items are rated on a 7-point Likert-type scale (1 = disagree strongly; 7 = agree strongly). The total score is a sum of ten items, ranging from 10 to 70 where a higher score means greater adherence.

Time frame:
Three months
Reported as:
Mean · score on a scale
Intervention Acceptability
score on a scaleOnline Yoga Intervention
Intervention Acceptability58 ± 5.6
PrimaryIntervention Satisfaction

The investigators will use modified versions of the Client Satisfaction Questionnaire (CSQ) to assess the satisfaction of the yoga intervention at 3-month follow-up. The CSQ is an 8-item self-report questionnaire to evaluate participant satisfaction with a specific intervention. Items are rated on a 4-point Likert-type scale (1 = very satisfied; 4= quite dissatisfied). The total score is the sum of eight items, ranging from 8 to 32, where a higher score indicates greater satisfaction with the intervention. This instrument was validated for patients and has internal consistency reliability.

Time frame:
Three months
Reported as:
Mean · score on a scale
Intervention Satisfaction
score on a scaleOnline Yoga Intervention
Intervention Satisfaction26.2 ± 8.3
SecondaryChange in Patient Health Questionnaire-9

The Patient Health Questionnaire-9 (PHQ-9) was developed to correspond to symptoms used in the DSMV-IV to diagnose clinical depression. Nine symptoms are rated on a 4-point Likert scale (0 = 'Not at all; 3 = 'Nearly every day'), with possible total scores ranging from 0 to 27 and higher scores indicating higher levels of depressive symptoms.

Time frame:
Baseline and Three months
Reported as:
Mean · score on a scale
Change in Patient Health Questionnaire-9
score on a scaleControlOnline Yoga Intervention
Change in Patient Health Questionnaire-92.7 ± 3.01.6 ± 1.2
SecondaryChange in Brief Symptom Inventory

The Brief Symptom Inventory (BSI), anxiety index, consists of 6 items rated on a 5-point Likert scale (0 = not at all; 4 = extremely). The total score ranges from 0 to 24, with a higher score reflecting greater anxiousness.

Time frame:
Baseline and Three months
Reported as:
Mean · score on a scale
Change in Brief Symptom Inventory
score on a scaleControlOnline Yoga Intervention
Change in Brief Symptom Inventory1.2 ± 0.21.2 ± 1.1
SecondaryChange in Vulnerable Elders Survey 13

The Vulnerable Elders Survey 13 (VES-13) includes four dimensions: age, self-assessment of health, physical function, and living function. Each domain is scored differently. Age is scored as follows: 75-84 years = 1 point, ≥ 85 years = 3 points. Self-rated health is categorized into "fair and poor" or "good", "very good", or "excellent", with only the "fair and poor" category scoring 1 point. The total score ranges from 0 to 15, with higher scores indicating greater vulnerability.

Time frame:
Baseline and Three months

No measurements were reported for this outcome.

SecondaryChange in Short-term Heart Rate Variability

Short-term Heart Rate Variability (HRV) will be collected using the Polar H9 heart rate monitor (Polar Electro OY, Kempele, Finland). The investigator will send a reminder about the precautions to be taken (e.g., avoiding caffeine, alcohol, smoking, and intense physical activity, as these factors could affect the HRV measurement for successful HRV measurement the day before the scheduled test. The investigator will again ask if the instructions have been followed when they arrive for data collection. Study patients will be instructed to lay supine for 10 minutes without speaking and to remain as still as possible. The investigator will place the Polar H9 heart rate monitor on the center of the sternum to measure HRV. During HRV data collection, the study patients will also wear the ActiGraph on the waist because the Polar H9 communicates with the ActiGraph.

Time frame:
Baseline and Three months
Reported as:
Number · units on a scale
Change in Short-term Heart Rate Variability
units on a scaleControlOnline Yoga Intervention
Change in Short-term Heart Rate Variability00
SecondaryMuscle Strength at Baseline

Muscle strengths will be measured using the handheld dynamometry (HHD, Lafayette dynamometer, model01165APP; Lafayette Instrument Company, Lafayette, Ind., USA). This device measures the peak force exerted in kilograms for five seconds during muscle contraction on hips and quadriceps.

Time frame:
Baseline
Reported as:
Mean · peak force (kgf)
Muscle Strength at Baseline
peak force (kgf)ControlOnline Yoga Intervention
Hip, Right, Baseline18.5 ± 6.618.7 ± 6.1
Hip, Left, Baseline17.8 ± 7.318.2 ± 7.6
Quadricep, Right, Baseline58.2 ± 21.851.2 ± 23.3
Quadricep, Left, Baseline54.6 ± 19.449.4 ± 22.5
SecondaryChange in Balance

Balance will be measured using an Inertial Measurement Unit device (DOTIMU; Xsens Technologies, Enschede., the Netherlands). The investigators attach the IMU sensor (a small device the size of a large watch face) to the participant's lower back at the level of L3 vertebra. Patients will be asked to take off their shoes and stand up on the mat with their hands on their hips for 30 seconds. The investigators will measure balance 3 times, with 30 seconds of rest between assessments. The total estimated time for the balance test is 3-5 minutes. All signal processing, subsequent feature extraction, and analysis will be performed using MATLAB version R2018B (The Mathworks Inc., Natick, MA, USA). The root-mean-square (RMS) value of the acceleration signal will be used to quantify the magnitude and trajectory of postural sway in each direction. The RMS of the magnitude vector of the 3-axis acceleration signal will be used as the summary score.

Time frame:
Baseline and Three months
Reported as:
Mean · meters per second squared
Change in Balance
meters per second squaredControlOnline Yoga Intervention
Change in Balance0.0 ± 1.200.2 ± 1.64
SecondaryChange in Physical Activity

Physical activity (PA) will be measured using actigraphy, the gold-standard for measuring physical activity. The investigator will use the ActiGraph (GT3X Link model), a triaxial instrument, which is the most widely used wearable accelerometer in clinical research. All patients will be instructed to wear the device for nine consecutive days, including at least one weekend day. Both baseline and 3-month values were calculated in a similar way.

Time frame:
Baseline and Three months
Reported as:
Mean · minutes per day
Change in Physical Activity
minutes per dayControlOnline Yoga Intervention
Change in Physical Activity5.6 ± 197.519.6 ± 122.4
SecondaryMuscle Strength at 3 Months

Muscle strengths will be measured using the handheld dynamometry (HHD, Lafayette dynamometer, model01165APP; Lafayette Instrument Company, Lafayette, Ind., USA). This device measures the peak force exerted in kilograms for five seconds during muscle contraction on hips and quadriceps.

Time frame:
Three months
Reported as:
Mean · peak force (kgf)
Muscle Strength at 3 Months
peak force (kgf)ControlOnline Yoga Intervention
Hip, Right, 3-month17.2 ± 6.222.8 ± 6.9
Hip, Left, 3-month15.8 ± 5.320.3 ± 6.1
Quadricep, Right, 3-month56.8 ± 27.763.2 ± 25.0
Quadricep, Left, 3-month48.5 ± 19.759.7 ± 24.5

Adverse events

Collected over 12-weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control0/15 (0%)0/15 (0%)0/15 (0%)
Online Yoga Intervention0/16 (0%)0/16 (0%)0/16 (0%)

Baseline characteristics

Baseline measures are only reported for study participants who completed all of baseline and 3-month assessments

Age, Categorical
Age, Categorical(Participants)ControlOnline Yoga InterventionTotal
<=18 years000
Between 18 and 65 years000
>=65 years151631
Age, Continuous
Age, Continuous(years)ControlOnline Yoga InterventionTotal
Mean73 ± 675 ± 1074 ± 6
Sex: Female, Male
Sex: Female, Male(Participants)ControlOnline Yoga InterventionTotal
Female538
Male101323
Race (NIH/OMB)
Race (NIH/OMB)(Participants)ControlOnline Yoga InterventionTotal
American Indian or Alaska Native000
Asian101
Native Hawaiian or Other Pacific Islander000
Black or African American101
White131629
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)ControlOnline Yoga InterventionTotal
United States151631
08

Study locations

1 site
  • University of Kentucky
    Lexington, Kentucky 40526, United States
09

References and documents

Study documents

  • Protocol and informed consent form · Aug 6, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06235658
Lead sponsor
Geunyeong Cha
Responsible party
Geunyeong Cha (Principal Investigator, University of Kentucky) — Sponsor-investigator
First posted
Feb 1, 2024
Start date
Nov 15, 2023
Primary completion
Nov 26, 2024
Completion
Nov 26, 2024
Results posted
Feb 27, 2026
Last update
Feb 27, 2026

Study contacts

Debra K Moser, Ph.D
study chair · University of Kentucky

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion